Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Radiation Protection

News
MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System
10/29/2024
MedLumics, a medical device company developing fiber optically guided platform technologies for the treatment, initially, of Atrial fibrillation (AF), announced today 10 patients treated in the company’s First in Man clinical trial.
MedLumics, a medical device company developing fiber optically guided platform technologies for the treatment, initially, of Atrial fibrillation (AF), announced today 10 patients treated in the company’s First in Man clinical trial.
MedLumics, a medical device...
10/29/2024
EP Lab Digest
News
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
10/29/2024
iRhythm Technologies, Inc., announces that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients with Hypertrophic Cardiomyopathy (EXAMINE-HCM) study have been...
iRhythm Technologies, Inc., announces that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients with Hypertrophic Cardiomyopathy (EXAMINE-HCM) study have been...
iRhythm Technologies, Inc.,...
10/29/2024
EP Lab Digest
Orsif
meeting update
Inaugural Global Symposium on Interventional Radiation Protection to Focus on Keeping Lab-Based Clinicians Safe
10/28/2024
HMP Global, in partnership with Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), will host the first-of-its-kind Global Symposium on Interventional Radiation Protection (SIRP), to be held September 26-27, 2025.
HMP Global, in partnership with Occupational Radiation Safety in Interventional Fluoroscopy (ORSIF), will host the first-of-its-kind Global Symposium on Interventional Radiation Protection (SIRP), to be held September 26-27, 2025.
HMP Global, in partnership with...
10/28/2024
EP Lab Digest
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the pre-defined performance goal (see figure 1).
Mechanical Circulatory Support
TCT: Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI
10/28/2024
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the...
The pivotal investigational device exemption (IDE) study, which enrolled 256 patients at 18 sites in the US, met the primary endpoint. MACCE (Major Adverse Cardiac and Cerebrovascular Events) rate at 30 days was 6.3%, significantly below the...
The pivotal investigational...
10/28/2024
Cath Lab Digest
News
A New Paradigm in Electrophysiology: Medtronic Receives FDA Approval of Affera™ Mapping and Ablation System and Sphere-9™ Catheter
10/25/2024
Medtronic Press Release  GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the...
Medtronic Press Release  GALWAY, Ireland, Oct. 24, 2024 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the...
Medtronic Press...
10/25/2024
EP Lab Digest
News
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
10/24/2024
Adagio Medical Holdings, Inc., announces the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System.
Adagio Medical Holdings, Inc., announces the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration (FDA) Pivotal IDE study of Adagio’s VT Cryoablation System.
Adagio Medical Holdings, Inc.,...
10/24/2024
EP Lab Digest
Ahead of Print
The STYLE-AF Study: Implications on Clinical Practice and Future Directions
10/24/2024
In this interview, EP Lab Digest speaks with Sorin Ștefan Popescu, MD, and Roland Richard Tilz, MD, about their research comparing the safety and efficacy of a venous vascular closure system to the standard of care (figure-of-8 suture and...
In this interview, EP Lab Digest speaks with Sorin Ștefan Popescu, MD, and Roland Richard Tilz, MD, about their research comparing the safety and efficacy of a venous vascular closure system to the standard of care (figure-of-8 suture and...
In this interview, EP Lab Digest...
10/24/2024
EP Lab Digest
News
Innovative Health Commits to Ambitious 2030 Greenhouse Gas Reduction Goal
10/24/2024
The reprocessing company seeks to further improve its already impressive impact on greenhouse gas emissions in healthcare
The reprocessing company seeks to further improve its already impressive impact on greenhouse gas emissions in healthcare
The reprocessing company seeks...
10/24/2024
EP Lab Digest
News
Catheter Precision Announces Clinical Publication of Non-Invasive Stereotactic Radioablation Using VIVO
10/22/2024
Catheter Precision Press Release  FORT MILL, SC / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac...
Catheter Precision Press Release  FORT MILL, SC / October 21, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac...
Catheter Precision Press...
10/22/2024
EP Lab Digest
News
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for...
Philips portfolio of...
10/21/2024
EP Lab Digest

Advertisement

EPLD November 2024 cover

Current Issue

November 2024
Volume 24
Issue 11
Current Issue
Issue Archive

Advertisement

Advertisement

Stay in the know.

EP Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement